DarioHealth

Company Overview

Snapshot

Founded in September 2011 by Dov Oppenheim, DarioHealth operates with 201–500 employees. The company has raised a total of $244.61M across 17 funding rounds from 13 investors. In February 2013, DarioHealth went public on NASDAQ.

Business overview

DarioHealth is a global digital therapeutics company that aims to transform how individuals manage chronic conditions. The company's core offering includes AI-powered digital therapeutic solutions for diabetes and hypertension, designed to drive behavior change through evidence-based interventions, high-quality software, coaching, and clinically proven digital tools. Operating at the intersection of life sciences, behavioral science, and software technology, DarioHealth serves markets in digital healthcare and patient engagement, expanding into new chronic conditions and geographic regions.

Strategic signal

In September 2025, DarioHealth announced a strategic review following multiple unsolicited inbound expressions of interest, indicating potential significant corporate developments. This suggests the company is exploring strategic options that could lead to a major transaction, such as an acquisition or a substantial partnership, signaling a pivotal moment for its future trajectory and investor value.

Company Intelligence Q&A

What was DarioHealth's most recent funding event?

In September 2025, DarioHealth announced a private placement of common stock, raising $17.5 million.

When did DarioHealth go public?

DarioHealth went public on NASDAQ in February 2013.

What was a significant acquisition made by DarioHealth recently?

In February 2024, DarioHealth acquired Twill, creating a comprehensive digital health platform across multiple chronic conditions.

What strategic collaboration did DarioHealth announce in October 2025?

In October 2025, DarioHealth and OneStep announced a strategic collaboration to integrate smartphone-only, clinical-grade fall risk assessment technology into Dario's digital health multi-condition platform.

What research did DarioHealth publish in September 2023?

In September 2023, DarioHealth published new research demonstrating clinically significant reductions in depression through its digital behavioral health programs.